Daron Evans

Insider Reports History

Location
South Orange, NJ
Signature
/s/ Daron Evans
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daron Evans:

Company Role Class Num Shares Value Price $ Report Date Ownership
Rezolute, Inc. CFO Common Shares 404,462 $1,350,903 $3.34 02 Mar 2026 Direct
NEPHROS INC CEO Specialty Renal Products Common Stock 134,215 $295,622 $2.20 24 May 2021 Direct
Rezolute, Inc. CFO Common Shares 40,000 $133,600 $3.34 02 Mar 2026 Held by PoC Capital LLC
Rezolute, Inc. CFO Common Shares 23,000 $76,820 $3.34 02 Mar 2026 Held by minor child #1
Rezolute, Inc. CFO Common Shares 20,000 $66,800 $3.34 02 Mar 2026 Held by spouse
Rezolute, Inc. CFO Common Shares 7,000 $23,380 $3.34 02 Mar 2026 Held by minor child #2
Rezolute, Inc. CFO Common Shares 7,000 $23,380 $3.34 02 Mar 2026 Held by minor child #3
NEPHROS INC CEO Specialty Renal Products Common Stock 8,947 $19,707 $2.20 27 May 2021 By UTMA #1
NEPHROS INC CEO Specialty Renal Products Common Stock 8,669 $19,094 $2.20 27 May 2021 By UTMA #2
NEPHROS INC CEO Specialty Renal Products Common Stock 6,111 $13,460 $2.20 24 May 2021 By PoC Capital, LLC
NEPHROS INC CEO Specialty Renal Products Common Stock 888 $1,956 $2.20 24 May 2021 By UTMA #3
NEPHROS INC CEO Specialty Renal Products Common Stock 888 $1,956 $2.20 24 May 2021 By UTMA #4
Rezolute, Inc. CFO Employee Stock Option (Right to Buy) 63,000 19 Nov 2025 Direct
NEPHROS INC CEO Specialty Renal Products Stock Option (Right to Buy) 20,000 24 May 2021 Direct
NEPHROS INC CEO Specialty Renal Products Common Stock Warrants (Right to Buy) 0 24 May 2021 By UTMA #1
NEPHROS INC CEO Specialty Renal Products Common Stock Warrants (Right to Buy) 0 24 May 2021 By UTMA #2

Insider Reports Filed by Daron Evans

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RZLT Rezolute, Inc. 02 Mar 2026 1 $0 4 CFO 04 Mar 2026, 18:16
RZLT Rezolute, Inc. 15 Dec 2025 3 +$79,578 4 CFO 15 Dec 2025, 19:35
RZLT Rezolute, Inc. 19 Nov 2025 2 $0 4 CFO 21 Nov 2025, 17:31
RZLT Rezolute, Inc. 24 Jun 2025 1 +$20,250 4 CFO 24 Jun 2025, 12:41
RZLT Rezolute, Inc. 10 Jun 2025 2 $0 4 CFO 12 Jun 2025, 21:29
RZLT Rezolute, Inc. 26 Mar 2025 2 +$57,700 4 CFO 28 Mar 2025, 08:40
RZLT Rezolute, Inc. 16 Feb 2025 2 $0 4 CFO 19 Feb 2025, 21:29
RZLT Rezolute, Inc. 18 Dec 2024 1 +$42,900 4 CFO 18 Dec 2024, 18:01
RZLT Rezolute, Inc. 12 Dec 2024 1 +$41,400 4 CFO 12 Dec 2024, 16:54
RZLT Rezolute, Inc. 09 Dec 2024 1 +$53,167 4 CFO 10 Dec 2024, 09:11
RZLT Rezolute, Inc. 23 Sep 2024 1 $0 4 CFO 24 Sep 2024, 13:03
RZLT Rezolute, Inc. 14 Jun 2024 1 +$161,568 4 CFO 14 Jun 2024, 12:06
RZLT Rezolute, Inc. 29 May 2024 1 +$1,578 4 CFO 31 May 2024, 16:05
RZLT Rezolute, Inc. 23 May 2024 2 +$9,668 4 CFO 28 May 2024, 14:48
RZLT Rezolute, Inc. 15 Mar 2024 1 +$33,830 4 CFO 19 Mar 2024, 09:17
RZLT Rezolute, Inc. 08 Mar 2024 1 +$96,345 4 CFO 08 Mar 2024, 12:37
RZLT Rezolute, Inc. 16 Feb 2024 3 +$66,741 4 CFO 20 Feb 2024, 07:01
RZLT Rezolute, Inc. 23 Jan 2024 1 $0 4 CFO 25 Jan 2024, 12:47
RZLT Rezolute, Inc. 22 Jan 2024 0 $0 3 CFO 25 Jan 2024, 12:46
NEPH NEPHROS INC 24 May 2021 2 -$1,885 4/A CEO Specialty Renal Products 01 Jun 2021, 17:39